Jianfang Ning

852 citations
18 papers · 563 indexed · h-index 10
Topics
CAR-T cell therapy research (9 papers)Virus-based gene therapy research (7 papers)Glioma Diagnosis and Treatment (5 papers)

In The Last Decade

Jianfang Ning

18 papers receiving 560 citations

Peers

Jianfang Ning
Comparison fields: 5 of 52
  • Oncology 297
  • Molecular Biology 293
  • Genetics 218
  • Genetics 129
  • Cancer Research 78
Replace Jenneke J. Kloezeman with:
Jenneke J. Kloezeman Netherlands
Chelsea Bolyard United States
Anna C. Filley United States
F. Lang United States
Andrea G. Manzanera United States
Naiara Martínez-Vélez Spain
Emmanuel Ravet France
Maija Kossila Finland
Richard Kay United Kingdom
George Buchlis United States
Jianfang Ning relative to Jenneke J. Kloezeman Netherlands Jenneke J. Kloezeman's profile →
Citations per field
00.5×1.5×1.9×
Jenneke J. Kloezeman · 1×
Citations per year

Countries citing papers authored by Jianfang Ning

Since Specialization
Citations

This map shows the geographic impact of Jianfang Ning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianfang Ning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianfang Ning more than expected).

Fields of papers citing papers by Jianfang Ning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianfang Ning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianfang Ning. The network helps show where Jianfang Ning may publish in the future.

Co-authorship network of co-authors of Jianfang Ning

This figure shows the co-authorship network connecting the top 25 collaborators of Jianfang Ning. A scholar is included among the top collaborators of Jianfang Ning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianfang Ning. Jianfang Ning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 1
2 1
3 88
4 37
5 11
6 50
7 7
8 3
9 1
10 2
11 61
12 30
13 1
14 3
15 41
16 13
17 45
18 168

About Jianfang Ning

Jianfang Ning is a scholar working on Oncology, Genetics and Genetics, having authored 18 papers that have together received 563 indexed citations. Recurring topics across this work include CAR-T cell therapy research (9 papers), Virus-based gene therapy research (7 papers) and Glioma Diagnosis and Treatment (5 papers). The work is most often cited by research in Genetics (129 citations), Oncology (297 citations) and Genetics (218 citations). Jianfang Ning has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Hiroaki Wakimoto, Samuel D. Rabkin, Robert L. Martuza, Peter E. Fecci, Tooba A. Cheema, Toshihiko Kuroda, Deva S. Jeyaretna, Daniel P. Cahill, Mara V.A. Koerner and Fumi Higuchi. Their work appears in journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026